ADDvise Group (ADDV) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
29 Apr, 2026Executive summary
Net revenue declined 15.7% year-over-year to SEK 357.4 million, with a 7.2% organic decrease and 8.5% negative currency impact.
Order intake grew 2.6% year-over-year, with 13.3% organic growth in local currency, offset by -10.7% currency effects.
EBITA fell 39.6% to SEK 45.5 million, with margin dropping to 12.7% from 17.8%.
Profit for the period was SEK 8.4 million, down from SEK 25.6 million; adjusted profit was SEK 14.1 million.
Cash flow from operating activities improved by 12.7% to SEK 41.2 million.
Financial highlights
Operating profit (EBIT) was SEK 39.0 million, down from SEK 69.3 million year-over-year.
Basic earnings per share were SEK 0.01, compared to SEK 0.10 in the prior year.
Gross margin remained stable at 54.3%.
Net debt stood at SEK 1,174.8 million, with net debt to EBITDA at 4.1x.
Equity ratio improved to 39.0% from 24.1%.
Outlook and guidance
Focus remains on strengthening profitability, improving capital efficiency, and reducing debt.
Continued evaluation of selective acquisitions to enhance market position and earnings.
Underlying demand expected to remain stable despite current market headwinds.
Latest events from ADDvise Group
- Revenue and profit fell, but order intake and cash flow rose as the group transitioned under new ownership.ADDV
Q2 2026 - Q4 saw higher EBITA margin, improved cash flow, and delisting after Amplex's takeover.ADDV
Q4 2025 - Profitability and cash flow rose on higher margins and lower financing costs, despite sales declines.ADDV
Q3 2025 - Margins and cash flow improved as new financing reduced debt and supported growth.ADDV
Q2 2025 - Sales and order intake up 26% and 17%, but margins fell and net debt rose amid tough comparables.ADDV
Q3 2024 - Sales up 20% with record orders, but organic growth and margins under pressure; liquidity remains strong.ADDV
Q2 2024 - Sales up 2.6–3%, EBITA margin 17.8–18%, and SEK 457m rights issue cut leverage.ADDV
Q1 2025 - Q4 2024 saw 11% sales growth and a SEK 457m rights issue to reduce debt and support growth.ADDV
Q4 2024